TYRA - Tyra Biosciences GAAP EPS of -$0.31
2023-08-11 16:23:04 ET
More on Tyra Biosciences
- Tyra Biosciences: Early Stage Developer Of Novel FGFR3-Selective Molecules
- Tyra Biosciences gets FDA orphan drug designation for dwarfism therapy
- Tyra Biosciences soars over 50% on public debut
- Precision oncology firm Tyra Biosciences prices upsized 11M-share IPO at $17
- Seeking Alpha’s Quant Rating on Tyra Biosciences
- Earnings data for Tyra Biosciences
For further details see:
Tyra Biosciences GAAP EPS of -$0.31